P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results

The requested reference [3c1707d671559dfddf9ed71be64c13312435c3fc] no longer exists in our database. It has been replaced by the current reference: [fde269c4f9d23309a7c8661b20db7ff5e6fcaa80]

Authors
Category Primary study
JournalClinical Lymphoma, Myeloma and Leukemia
Year 2021
This article has no abstract
Epistemonikos ID: 09267368484dbd7897f69a54b85edc5c1909020b
First added on: Feb 13, 2025